3 best performing ASX shares in the week of 1 August 2022

Marc Kennis Marc Kennis, August 8, 2022

Best performing ASX shares

The three best performing ASX shares in the week of 1 August 2022 were Plexure Group (ASX:PX1), up 97.1%, Resapp Health (ASX:RAP), up 65.2%, and Paradigm Biopharmaceuticals (ASX:PAR), up 52.2%.

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

 

1. Plexure Group (ASX:PX1)

Industry: Software & IT Services

Plexure Group Limited (ASX:PX1) is a global mobile engagement company helping brands create sticky and more profitable relationships with consumers. Harnessing the power of consumer, contextual, behavioral and sales data, we enable the delivery of deeply personalized compelling offers to customers through mobile channels.

Market Cap: $118m

12 month high / low: $0.125 – $0.73

 

Plexure

 

 

2. Resapp Health (ASX:RAP)

Industry: Technology

ResApp Health Limited (ASX:RAP) is a digital health company developing smartphone applications for the diagnosis and management of respiratory disease. The technology is based on machine learning algorithms that use cough sounds to diagnose and measure the severity of respiratory conditions without the need for additional hardware.

Market Cap: $163M

12 month high / low: $0.042 – $0.1975

 

ResApp

 

 

3. Paradigm Biopharmaceuticals (ASX:PAR)

Industry: Healthcare

Paradigm Biopharmaceuticals Limited (ASX:PAR) wraps our 3 best performing ASX shares this week. PAR is involved in researching and developing therapeutic products for human use. It is a drug repurposing company, which seeks to find new uses for old drugs, thereby reducing the cost and time to bring therapeutics to market. 

Market Cap: $392m

12 month high / low: $0.855 – $2.69

 

Paradigm Biopharmaceuticals

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Nuix

Nuix (ASX:NXL) has quadrupled in 12 months! But is more growth to come?

Nuix (ASX:NXL) has been one of the most controversial companies on the ASX since it listed, but has it turned…

ASX Biotechs

Here are 3 ASX biotechs with major milestones coming right up!

Investing in ASX biotechs is a risky business, even more than most other companies on the market. Unless you own…

buy the dip

When do you know it’s time to ‘buy the dip’? You could be catching a falling knife

‘Buy the dip’ – have you ever heard that term? It implies that when a company’s share price ‘dips’ or decreases,…